Inflammasome activation and vitiligo/nonsegmental vitiligo progression

Polymorphisms of NLR (nucleotide‐binding domain and leucine rich repeat containing) family, pyrin domain containing protein 1 (NLRP1) have been found in patients with vitiligo/nonsegmental vitiligo (NSV), and increased NLRP1 expression has been detected in the leading edge of lesional skin biopsies.

[1]  M. Mansuri,et al.  Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population , 2013, The British journal of dermatology.

[2]  A. Alkhateeb,et al.  Polymorphisms in NLRP1 gene and susceptibility to autoimmune thyroid disease , 2013, Autoimmunity.

[3]  R. Spritz,et al.  NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome , 2013, Proceedings of the National Academy of Sciences.

[4]  Shi Weimin,et al.  Global Activation of CD8+ Cytotoxic T Lymphocytes Correlates with an Impairment in Regulatory T Cells in Patients with Generalized Vitiligo , 2012, PloS one.

[5]  M. Picardo,et al.  Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference , 2012, Pigment cell & melanoma research.

[6]  A. Taïeb.  Vitiligo as an inflammatory skin disorder: a therapeutic perspective , 2012, Pigment cell & melanoma research.

[7]  T. Jouary,et al.  Multivariate analysis of factors associated with early‐onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients , 2011, The British journal of dermatology.

[8]  S. Deo,et al.  GENETIC VARIATIONS IN NALP1 MRNA EXPRESSIONS IN HUMAN VITILIGO , 2011, Indian journal of dermatology.

[9]  Dariush Moussai,et al.  Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo Lesions , 2011, PloS one.

[10]  G. Girolomoni,et al.  The Role of Innate Immunity in Vitiligo , 2010 .

[11]  B. Lie,et al.  A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes , 2009, Genes and Immunity.

[12]  J. Tschopp,et al.  The inflammasome: a danger sensing complex triggering innate immunity. , 2007, Current opinion in immunology.

[13]  A. Taïeb.  NALP1 and the inflammasomes: challenging our perception of vitiligo and vitiligo-related autoimmune disorders. , 2007, Pigment cell research.

[14]  S. Werner,et al.  The Inflammasome Mediates UVB-Induced Activation and Secretion of Interleukin-1β by Keratinocytes , 2007, Current Biology.

[15]  F. Martinon,et al.  Inflammasome Components NALP 1 and 3 Show Distinct but Separate Expression Profiles in Human Tissues Suggesting a Site-specific Role in the Inflammatory Response , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[16]  Sheri L. Riccardi,et al.  NALP1 in vitiligo-associated multiple autoimmune disease. , 2007, The New England journal of medicine.

[17]  M. Picardo,et al.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. , 2007, Pigment cell research.

[18]  R. Boissy,et al.  4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. , 2005, The Journal of investigative dermatology.

[19]  W. Westerhof,et al.  Local Immune Response in Skin of Generalized Vitiligo Patients , 2000, Laboratory Investigation.

[20]  T. Egelrud,et al.  Biologically active, alternatively processed interleukin‐1β in psoriatic scales , 1997 .

[21]  T. Egelrud,et al.  Biologically active, alternatively processed interleukin-1 beta in psoriatic scales. , 1997, European journal of immunology.

[22]  J. Garioch,et al.  An immunohistological study of cutaneous lymphocytes in vitiligo , 1993, The Journal of pathology.

[23]  J. Bystryn,et al.  Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. , 1991, The Journal of investigative dermatology.

[24]  G. Naughton,et al.  Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. , 1986, Journal of the American Academy of Dermatology.

[25]  G. Naughton,et al.  Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation. , 1983, The Journal of investigative dermatology.